{"id":"W2729990002","doi":"10.1177/1753944717714921","title":"Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Cardiovascular Disease","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada); McMaster University","funders":"Bayer Canada","keywords":"Medicine; Edoxaban; Dabigatran; Apixaban; Rivaroxaban; Dosing; Renal function; Pharmacodynamics; Atrial fibrillation; Intensive care medicine; Internal medicine; Pharmacology; Pharmacokinetics; Warfarin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004673733,0.00009164375,0.0004360429,0.0004819466,0.0003384124,0.0004953454,0.0001641196,0.0003080501,0.002240074],"category_scores_gemma":[0.002518897,0.00005878597,0.0005524486,0.0008239386,0.0001251592,0.0003823185,0.000266356,0.0005861949,0.0003696922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002983946,"about_ca_system_score_gemma":0.0006931436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002542199,"about_ca_topic_score_gemma":0.00295018,"domain_scores_codex":[0.9993766,0.0001541209,0.0001249391,0.00005316006,0.0002052023,0.00008606918],"domain_scores_gemma":[0.9990589,0.0002431298,0.0003869663,0.00003250383,0.0001458458,0.0001326784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008238301,0.0003915763,0.7618083,0.001625824,0.0003742135,0.002386932,0.0006312438,0.000184323,0.001109011,0.0007912193,0.01154527,0.2183283],"study_design_scores_gemma":[0.0001906442,0.000924754,0.9203765,0.002087021,0.0005998935,0.01245029,0.0007489275,0.0005168664,0.0006198122,0.00126557,0.06016623,0.00005355253],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7704123,0.1548781,0.001044949,0.0110988,0.0006345051,0.0002441891,0.002063809,0.00005288409,0.05957038],"genre_scores_gemma":[0.9619075,0.03120637,0.0005469687,0.00243983,0.0006173017,0.00006044439,0.0008056502,0.0000067937,0.002409133],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.002542199,"threshold_uncertainty_score":0.007493734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1014224525303861,"score_gpt":0.3760838915780124,"score_spread":0.2746614390476263,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}